Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 57

  • Showing results for van megen _hj. Your search for vanMegen_HJ retrieved no results.
1.

Examining the factor structure of the self-report Yale-Brown Obsessive Compulsive Scale Symptom Checklist.

du Mortier JAM, Visser HAD, van Balkom AJLM, van Megen HJGM, Hoogendoorn AW, Glas G, van Oppen P.

Psychiatry Res. 2018 Nov 19;271:299-305. doi: 10.1016/j.psychres.2018.11.042. [Epub ahead of print]

PMID:
30521999
2.

The Efficacy of a Group CBT Relapse Prevention Program for Remitted Anxiety Disorder Patients Who Discontinue Antidepressant Medication: A Randomized Controlled Trial.

Scholten WD, Batelaan NM, van Oppen P, Smit JH, Hoogendoorn AW, van Megen HJGM, Cath DC, van Balkom AJLM.

Psychother Psychosom. 2018;87(4):240-242. doi: 10.1159/000489498. Epub 2018 Jun 1. No abstract available.

PMID:
29860251
3.

Chronic obsessive-compulsive disorder: prognostic factors.

van Oudheusden LJB, Eikelenboom M, van Megen HJGM, Visser HAD, Schruers K, Hendriks GJ, van der Wee N, Hoogendoorn AW, van Oppen P, van Balkom AJLM.

Psychol Med. 2018 Oct;48(13):2213-2222. doi: 10.1017/S0033291717003701. Epub 2018 Jan 9.

PMID:
29310732
4.

No Effects of D-Cycloserine Enhancement in Exposure With Response Prevention Therapy in Panic Disorder With Agoraphobia: A Double-Blind, Randomized Controlled Trial.

Hofmeijer-Sevink MK, Duits P, Rijkeboer MM, Hoogendoorn AW, van Megen HJ, Vulink NC, Denys DA, van den Hout MA, van Balkom AJ, Cath DC.

J Clin Psychopharmacol. 2017 Oct;37(5):531-539. doi: 10.1097/JCP.0000000000000757.

PMID:
28820746
5.

Presence and Predictive Value of Obsessive-Compulsive Symptoms in Anxiety and Depressive Disorders.

Hofmeijer-Sevink MK, Batelaan NM, van Megen HJGM, van den Hout MA, Penninx BW, van Balkom AJLM, Cath DC.

Can J Psychiatry. 2018 Feb;63(2):85-93. doi: 10.1177/0706743717711170. Epub 2017 May 16.

6.

d-cycloserine addition to exposure sessions in the treatment of patients with obsessive-compulsive disorder.

de Leeuw AS, van Megen HJ, Kahn RS, Westenberg HG.

Eur Psychiatry. 2017 Feb;40:38-44. doi: 10.1016/j.eurpsy.2016.06.011. Epub 2016 Nov 10.

PMID:
27837671
7.

Obsessive-compulsive disorder; chronic versus non-chronic symptoms.

Visser HA, van Oppen P, van Megen HJ, Eikelenboom M, van Balkom AJ.

J Affect Disord. 2014 Jan;152-154:169-74. doi: 10.1016/j.jad.2013.09.004. Epub 2013 Sep 13.

PMID:
24084621
8.

The association between CYP2D6 genotype and switching antipsychotic medication to clozapine.

Gregoor JG, van der Weide K, van der Weide J, van Megen HJ, Egberts AC, Heerdink ER.

Eur J Clin Pharmacol. 2013 Nov;69(11):1927-32. doi: 10.1007/s00228-013-1553-1. Epub 2013 Jul 7.

PMID:
23831869
9.

Clinical relevance of comorbidity in obsessive compulsive disorder: the Netherlands OCD Association study.

Hofmeijer-Sevink MK, van Oppen P, van Megen HJ, Batelaan NM, Cath DC, van der Wee NJ, van den Hout MA, van Balkom AJ.

J Affect Disord. 2013 Sep 25;150(3):847-54. doi: 10.1016/j.jad.2013.03.014. Epub 2013 Apr 15.

PMID:
23597943
10.

An evaluation of irreversible psychosurgical treatment of patients with obsessive-compulsive disorder in the Netherlands, 2001-2008.

van Vliet IM, van Well EP, Bruggeman R, Campo JA, Hijman R, van Megen HJ, van Balkom AJ, van Rijen PC.

J Nerv Ment Dis. 2013 Mar;201(3):226-8. doi: 10.1097/NMD.0b013e3182848b15.

PMID:
23443039
11.

The Netherlands Obsessive Compulsive Disorder Association (NOCDA) study: design and rationale of a longitudinal naturalistic study of the course of OCD and clinical characteristics of the sample at baseline.

Schuurmans J, van Balkom AJ, van Megen HJ, Smit JH, Eikelenboom M, Cath DC, Kaarsemaker M, Oosterbaan D, Hendriks GJ, Schruers KR, van der Wee NJ, Glas G, van Oppen P.

Int J Methods Psychiatr Res. 2012 Dec;21(4):273-85. doi: 10.1002/mpr.1372. Epub 2012 Nov 12.

PMID:
23148029
12.

[The characterisation of anxiety disorders: staging and profiling based on common sense].

van Balkom AJ, Oosterbaan DB, Batelaan N, Cath DC, Hendriks GJ, van Megen HJ, Schruers K, Spijker J, van der Wee N, van Vliet IM.

Tijdschr Psychiatr. 2012;54(11):935-40. Review. Dutch.

13.

Clinical relevance of comorbidity in anxiety disorders: a report from the Netherlands Study of Depression and Anxiety (NESDA).

Hofmeijer-Sevink MK, Batelaan NM, van Megen HJ, Penninx BW, Cath DC, van den Hout MA, van Balkom AJ.

J Affect Disord. 2012 Mar;137(1-3):106-12. doi: 10.1016/j.jad.2011.12.008. Epub 2012 Jan 10.

14.

Polymorphisms of the LEP, LEPR and HTR2C gene: obesity and BMI change in patients using antipsychotic medication in a naturalistic setting.

Gregoor JG, van der Weide J, Loovers HM, van Megen HJ, Egberts TC, Heerdink ER.

Pharmacogenomics. 2011 Jun;12(6):919-23. doi: 10.2217/pgs.11.40. Epub 2011 Apr 21.

PMID:
21510767
15.

[Is the MiniScan a useful psychiatric intervention? A pilot study of the incremental validity of a computerised classification system].

Damhuis N, van Megen HJ, Peeters CF, Vollema MG.

Tijdschr Psychiatr. 2011;53(3):175-80. Dutch.

16.

[The course of borderline personality disorder within adults. A literature review].

Vriend-Bosma SA, van Megen HJ.

Tijdschr Psychiatr. 2011;53(1):27-36. Review. Dutch.

17.

Paroxetine augmentation in patients with generalised social anxiety disorder, non-responsive to mirtazapine or placebo.

Schutters SI, van Megen HJ, Van Veen JF, Schruers KR, Westenberg HG.

Hum Psychopharmacol. 2011 Jan;26(1):72-6. doi: 10.1002/hup.1165. Epub 2011 Feb 9.

PMID:
23055414
18.

Combined HTR2C-LEP genotype as a determinant of obesity in patients using antipsychotic medication.

Gregoor JG, Mulder H, Cohen D, van Megen HJ, Egberts TC, Heerdink ER, van der Weide J.

J Clin Psychopharmacol. 2010 Dec;30(6):702-5.

PMID:
21105285
19.

Mirtazapine in generalized social anxiety disorder: a randomized, double-blind, placebo-controlled study.

Schutters SI, Van Megen HJ, Van Veen JF, Denys DA, Westenberg HG.

Int Clin Psychopharmacol. 2010 Sep;25(5):302-4.

PMID:
20715300
20.

Sensory gating and sensorimotor gating in medication-free obsessive-compulsive disorder patients.

de Leeuw AS, Oranje B, van Megen HJ, Kemner C, Westenberg HG.

Int Clin Psychopharmacol. 2010 Jul;25(4):232-40.

PMID:
20568657

Supplemental Content

Loading ...
Support Center